相关实验视频
Updated: Jul 17, 2026
36:30
Small Bowel Transplantation In Mice
Published on: August 20, 2007
14.7K
肝移植治疗肠道恶性瘤
Alessandro Vitale1, Gabriel Gondolesi2, Michele Finotti3
1Department of Surgical, Oncological, and Gastroenterological Sciences, Padua University, Padova, Italy.
概括
肝移植 (LT) 为某些转移性肠癌提供了有价值的治疗方法,包括结直肠肝转移 (CRLM) 和神经内分泌肝转移 (NELM). 精心选择患者和定义"移植益处"对于道德分配和改善生存结果至关重要.
科学领域:
- 癌症学
- 肝病学
- 移植手术
背景情况:
- 肝移植 (LT) 已经超越了原发性肝癌,包括大肠癌 (CRLM) 和神经内分泌肝癌 (NELM).
- 对于移植瘤,需要重新评估指示,患者选择和结果.
- 区分预后因素和选择标准对于准确的患者分层至关重要.
研究的目的:
- 审查LT在转移性肠癌管理中的演变作用.
- 在CRLM和NELM中探索患者选择标准和临床结果.
- 提出移植瘤学伦理分配和结果评估的框架.
主要方法:
- 目前文献和前性研究的审查 (例如,SECA I-II,TransMet试验).
- 对 LT 候选人的预后因素与选择标准的分析.
- 评估总生存率作为主要终点,与无复发生存率形成对比.
主要成果:
- 在精选的CRLM和NELM患者中,LT显示显著的生存益处.
- 估计的移植效益有所不同,每项方案的CRLM约为22.5个月,NELM约为12个月.
- 由于偏差,总体存活率是比无复发性存活率更可靠的终点.
结论:
- 在肠道恶性瘤中,谨慎的患者选择和伦理考虑至关重要.
- "移植福利"提供了一个公平的资源分配措施.
- 未来的方向包括扩大LT标准和加强协作瘤治理.
相关概念视频
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...